<?xml version="1.0"?>
<VGCodes>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTP</Value>
 <Name>CVXCode</Name>
 <Value>01        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>DTAP</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>107</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>OPV, trivalent</Value>
 <Name>CVXCode</Name>
 <Value>02        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>POLIO</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>89</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>MMR</Value>
 <Name>CVXCode</Name>
 <Value>03        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>MMR</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>03</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>M/R</Value>
 <Name>CVXCode</Name>
 <Value>04        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>MMR</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>03</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>measles</Value>
 <Name>CVXCode</Name>
 <Value>05        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>MMR</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>03</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>rubella</Value>
 <Name>CVXCode</Name>
 <Value>06        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>MMR</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>03</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>mumps</Value>
 <Name>CVXCode</Name>
 <Value>07        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>MMR</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>03</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hep B, adolescent or pediatric</Value>
 <Name>CVXCode</Name>
 <Value>08        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HepB</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>45</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed</Value>
 <Name>CVXCode</Name>
 <Value>09        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>Td</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>139</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>IPV</Value>
 <Name>CVXCode</Name>
 <Value>10        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>POLIO</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>89</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>pneumococcal conjugate PCV 7</Value>
 <Name>CVXCode</Name>
 <Value>100       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>PneumoPCV</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>152</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>typhoid, ViCPs</Value>
 <Name>CVXCode</Name>
 <Value>101       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>TYPHOID</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>91</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTP-Hib-Hep B</Value>
 <Name>CVXCode</Name>
 <Value>102       </Value>
 <Name>Status</Name>
 <Value>Non-US</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HIB</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>17</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTP-Hib-Hep B</Value>
 <Name>CVXCode</Name>
 <Value>102       </Value>
 <Name>Status</Name>
 <Value>Non-US</Value>
 <Name>Vaccine Group Name</Name>
 <Value>DTAP</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>107</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTP-Hib-Hep B</Value>
 <Name>CVXCode</Name>
 <Value>102       </Value>
 <Name>Status</Name>
 <Value>Non-US</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HepB</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>45</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>meningococcal C conjugate</Value>
 <Name>CVXCode</Name>
 <Value>103       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>MENING</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>108</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hep A-Hep B</Value>
 <Name>CVXCode</Name>
 <Value>104       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HepA</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>85</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hep A-Hep B</Value>
 <Name>CVXCode</Name>
 <Value>104       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HepB</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>45</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>vaccinia (smallpox) diluted</Value>
 <Name>CVXCode</Name>
 <Value>105       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>Orthopoxvirus</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>325</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP, 5 pertussis antigens</Value>
 <Name>CVXCode</Name>
 <Value>106       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>DTAP</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>107</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>107       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>DTAP</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>107</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>meningococcal ACWY, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>108       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>MENING</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>108</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>pneumococcal, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>109       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>PneumoPCV</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>152</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>pneumococcal, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>109       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>PneumoPPV</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>33</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP-Hep B-IPV</Value>
 <Name>CVXCode</Name>
 <Value>110       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>DTAP</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>107</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP-Hep B-IPV</Value>
 <Name>CVXCode</Name>
 <Value>110       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HepB</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>45</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP-Hep B-IPV</Value>
 <Name>CVXCode</Name>
 <Value>110       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>POLIO</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>89</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Influenza, live, trivalent, intranasal, PF</Value>
 <Name>CVXCode</Name>
 <Value>111       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed</Value>
 <Name>CVXCode</Name>
 <Value>113       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>Td</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>139</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>meningococcal MCV4P</Value>
 <Name>CVXCode</Name>
 <Value>114       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>MENING</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>108</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Tdap</Value>
 <Name>CVXCode</Name>
 <Value>115       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>TDAP</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>115</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>rotavirus, pentavalent</Value>
 <Name>CVXCode</Name>
 <Value>116       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>ROTAVIRUS</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>122</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>HPV, bivalent</Value>
 <Name>CVXCode</Name>
 <Value>118       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HPV</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>137</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>rotavirus, monovalent</Value>
 <Name>CVXCode</Name>
 <Value>119       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>ROTAVIRUS</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>122</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP-Hib-IPV</Value>
 <Name>CVXCode</Name>
 <Value>120       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>DTAP</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>107</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP-Hib-IPV</Value>
 <Name>CVXCode</Name>
 <Value>120       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>POLIO</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>89</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP-Hib-IPV</Value>
 <Name>CVXCode</Name>
 <Value>120       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HIB</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>17</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>zoster live</Value>
 <Name>CVXCode</Name>
 <Value>121       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>ZOSTER</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>188</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>rotavirus, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>122       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>ROTAVIRUS</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>122</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>influenza, H5N1-1203</Value>
 <Name>CVXCode</Name>
 <Value>123       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>H5N1 flu</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>123</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Novel Influenza-H1N1-09, nasal</Value>
 <Name>CVXCode</Name>
 <Value>125       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>H1N1 flu</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>128</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Novel influenza-H1N1-09, preservative-free</Value>
 <Name>CVXCode</Name>
 <Value>126       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>H1N1 flu</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>128</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Novel influenza-H1N1-09</Value>
 <Name>CVXCode</Name>
 <Value>127       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>H1N1 flu</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>128</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Novel Influenza-H1N1-09, all formulations</Value>
 <Name>CVXCode</Name>
 <Value>128       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>H1N1 flu</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>128</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Japanese Encephalitis, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>129       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>Japanese encephalitis</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>129</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP-IPV</Value>
 <Name>CVXCode</Name>
 <Value>130       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>POLIO</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>89</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP-IPV</Value>
 <Name>CVXCode</Name>
 <Value>130       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>DTAP</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>107</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP-IPV-HIB-HEP B, historical</Value>
 <Name>CVXCode</Name>
 <Value>132       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>DTAP</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>107</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP-IPV-HIB-HEP B, historical</Value>
 <Name>CVXCode</Name>
 <Value>132       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HIB</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>17</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP-IPV-HIB-HEP B, historical</Value>
 <Name>CVXCode</Name>
 <Value>132       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>POLIO</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>89</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP-IPV-HIB-HEP B, historical</Value>
 <Name>CVXCode</Name>
 <Value>132       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HepB</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>45</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Pneumococcal conjugate PCV 13</Value>
 <Name>CVXCode</Name>
 <Value>133       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>PneumoPCV</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>152</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Japanese Encephalitis IM</Value>
 <Name>CVXCode</Name>
 <Value>134       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>Japanese encephalitis</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>129</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Influenza, high-dose, trivalent, PF</Value>
 <Name>CVXCode</Name>
 <Value>135       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Meningococcal MCV4O</Value>
 <Name>CVXCode</Name>
 <Value>136       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>MENING</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>108</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>HPV, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>137       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HPV</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>137</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Td (adult)</Value>
 <Name>CVXCode</Name>
 <Value>138       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>Td</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>139</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Td(adult) unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>139       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>Td</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>139</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Influenza, split virus, trivalent, PF</Value>
 <Name>CVXCode</Name>
 <Value>140       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Influenza, split virus, trivalent, preservative</Value>
 <Name>CVXCode</Name>
 <Value>141       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Adenovirus types 4 and 7</Value>
 <Name>CVXCode</Name>
 <Value>143       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>ADENO</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>82</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>influenza, seasonal, intradermal, preservative free</Value>
 <Name>CVXCode</Name>
 <Value>144       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP,IPV,Hib,HepB</Value>
 <Name>CVXCode</Name>
 <Value>146       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>DTAP</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>107</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP,IPV,Hib,HepB</Value>
 <Name>CVXCode</Name>
 <Value>146       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HIB</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>17</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP,IPV,Hib,HepB</Value>
 <Name>CVXCode</Name>
 <Value>146       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HepB</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>45</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP,IPV,Hib,HepB</Value>
 <Name>CVXCode</Name>
 <Value>146       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>POLIO</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>89</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>meningococcal MCV4, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>147       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>MENING</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>108</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Meningococcal C/Y-HIB PRP</Value>
 <Name>CVXCode</Name>
 <Value>148       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>MENING</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>108</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Meningococcal C/Y-HIB PRP</Value>
 <Name>CVXCode</Name>
 <Value>148       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HIB</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>17</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Influenza, live, quadrivalent, intranasal</Value>
 <Name>CVXCode</Name>
 <Value>149       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>influenza, split (incl. purified surface antigen)</Value>
 <Name>CVXCode</Name>
 <Value>15        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Influenza, split virus, quadrivalent, PF</Value>
 <Name>CVXCode</Name>
 <Value>150       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>influenza nasal, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>151       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Pneumococcal Conjugate, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>152       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>PneumoPCV</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>152</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Influenza, MDCK, trivalent, PF</Value>
 <Name>CVXCode</Name>
 <Value>153       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Influenza, recombinant, trivalent, PF</Value>
 <Name>CVXCode</Name>
 <Value>155       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Influenza, split virus, quadrivalent, preservative</Value>
 <Name>CVXCode</Name>
 <Value>158       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>influenza, whole</Value>
 <Name>CVXCode</Name>
 <Value>16        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Influenza A monovalent (H5N1), ADJUVANTED-2013</Value>
 <Name>CVXCode</Name>
 <Value>160       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>H5N1 flu</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>123</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Influenza, injectable,quadrivalent, preservative free, pediatric</Value>
 <Name>CVXCode</Name>
 <Value>161       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>meningococcal B, recombinant</Value>
 <Name>CVXCode</Name>
 <Value>162       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>MeningB</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>164</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>meningococcal B, OMV</Value>
 <Name>CVXCode</Name>
 <Value>163       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>MeningB</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>164</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>meningococcal B, unspecified</Value>
 <Name>CVXCode</Name>
 <Value>164       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>MeningB</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>164</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>HPV9</Value>
 <Name>CVXCode</Name>
 <Value>165       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HPV</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>137</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>influenza, intradermal, quadrivalent, preservative free</Value>
 <Name>CVXCode</Name>
 <Value>166       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Influenza, adjuvanted, trivalent, PF</Value>
 <Name>CVXCode</Name>
 <Value>168       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hib, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>17        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HIB</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>17</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTAP/IPV/HIB - non-US</Value>
 <Name>CVXCode</Name>
 <Value>170       </Value>
 <Name>Status</Name>
 <Value>Non-US</Value>
 <Name>Vaccine Group Name</Name>
 <Value>POLIO</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>89</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTAP/IPV/HIB - non-US</Value>
 <Name>CVXCode</Name>
 <Value>170       </Value>
 <Name>Status</Name>
 <Value>Non-US</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HIB</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>17</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTAP/IPV/HIB - non-US</Value>
 <Name>CVXCode</Name>
 <Value>170       </Value>
 <Name>Status</Name>
 <Value>Non-US</Value>
 <Name>Vaccine Group Name</Name>
 <Value>DTAP</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>107</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Influenza, MDCK, quadrivalent, PF</Value>
 <Name>CVXCode</Name>
 <Value>171       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>cholera, WC-rBS</Value>
 <Name>CVXCode</Name>
 <Value>172       </Value>
 <Name>Status</Name>
 <Value>Non-US</Value>
 <Name>Vaccine Group Name</Name>
 <Value>cholera</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>26</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>cholera, BivWC</Value>
 <Name>CVXCode</Name>
 <Value>173       </Value>
 <Name>Status</Name>
 <Value>Non-US</Value>
 <Name>Vaccine Group Name</Name>
 <Value>cholera</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>26</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>cholera, live attenuated</Value>
 <Name>CVXCode</Name>
 <Value>174       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>cholera</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>26</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Rabies - IM Diploid cell culture</Value>
 <Name>CVXCode</Name>
 <Value>175       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>RABIES</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>90</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Rabies - IM fibroblast culture</Value>
 <Name>CVXCode</Name>
 <Value>176       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>RABIES</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>90</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>PCV10</Value>
 <Name>CVXCode</Name>
 <Value>177       </Value>
 <Name>Status</Name>
 <Value>Non-US</Value>
 <Name>Vaccine Group Name</Name>
 <Value>PneumoPCV</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>152</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>rabies, intramuscular injection</Value>
 <Name>CVXCode</Name>
 <Value>18        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>RABIES</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>90</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Yellow fever vaccine live - alt</Value>
 <Name>CVXCode</Name>
 <Value>183       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>YELLOWFEVER</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>184</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Yellow fever, unspecified</Value>
 <Name>CVXCode</Name>
 <Value>184       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>YELLOWFEVER</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>184</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Influenza, recombinant, quadrivalent, PF</Value>
 <Name>CVXCode</Name>
 <Value>185       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Influenza, MDCK, quadrivalent, preservative</Value>
 <Name>CVXCode</Name>
 <Value>186       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>zoster recombinant</Value>
 <Name>CVXCode</Name>
 <Value>187       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>ZOSTER</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>188</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>zoster, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>188       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>ZOSTER</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>188</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>HepB-CpG</Value>
 <Name>CVXCode</Name>
 <Value>189       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HepB</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>45</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>BCG</Value>
 <Name>CVXCode</Name>
 <Value>19        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>BCG</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>19</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hep A-Hep B, pediatric/adolescent</Value>
 <Name>CVXCode</Name>
 <Value>193       </Value>
 <Name>Status</Name>
 <Value>Non-US</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HepB</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>45</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hep A-Hep B, pediatric/adolescent</Value>
 <Name>CVXCode</Name>
 <Value>193       </Value>
 <Name>Status</Name>
 <Value>Non-US</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HepA</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>85</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Influenza, Southern Hemisphere</Value>
 <Name>CVXCode</Name>
 <Value>194       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DT, IPV adsorbed</Value>
 <Name>CVXCode</Name>
 <Value>195       </Value>
 <Name>Status</Name>
 <Value>Non-US</Value>
 <Name>Vaccine Group Name</Name>
 <Value>POLIO</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>89</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DT, IPV adsorbed</Value>
 <Name>CVXCode</Name>
 <Value>195       </Value>
 <Name>Status</Name>
 <Value>Non-US</Value>
 <Name>Vaccine Group Name</Name>
 <Value>Td</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>139</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Td, adsorbed, preservative free, adult use, Lf unspecified</Value>
 <Name>CVXCode</Name>
 <Value>196       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>Td</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>139</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Influenza, high-dose, quadrivalent, PF</Value>
 <Name>CVXCode</Name>
 <Value>197       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP</Value>
 <Name>CVXCode</Name>
 <Value>20        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>DTAP</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>107</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>influenza, Southern Hemisphere, pediatric, preservative free</Value>
 <Name>CVXCode</Name>
 <Value>200       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Influenza, Southern Hemisphere, quadrivalent, PF</Value>
 <Name>CVXCode</Name>
 <Value>201       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>influenza, Southern Hemisphere, quadrivalent, with preservative</Value>
 <Name>CVXCode</Name>
 <Value>202       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>meningococcal conjugate quadrivalent, MenACWY-TT (MCV4)</Value>
 <Name>CVXCode</Name>
 <Value>203       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>MENING</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>108</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Ebola Zaire vaccine, live, recombinant, 1mL dose</Value>
 <Name>CVXCode</Name>
 <Value>204       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>Ebola</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>214</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Influenza, adjuvanted, quadrivalent, PF</Value>
 <Name>CVXCode</Name>
 <Value>205       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Vaccinia, smallpox monkeypox vaccine live, PF, SQ or ID injection</Value>
 <Name>CVXCode</Name>
 <Value>206       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>Orthopoxvirus</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>325</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose</Value>
 <Name>CVXCode</Name>
 <Value>207       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose</Value>
 <Name>CVXCode</Name>
 <Value>208       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>varicella</Value>
 <Name>CVXCode</Name>
 <Value>21        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>VARICELLA</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>21</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL</Value>
 <Name>CVXCode</Name>
 <Value>210       </Value>
 <Name>Status</Name>
 <Value>Non-US</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL</Value>
 <Name>CVXCode</Name>
 <Value>211       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL</Value>
 <Name>CVXCode</Name>
 <Value>212       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED</Value>
 <Name>CVXCode</Name>
 <Value>213       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Ebola, unspecified</Value>
 <Name>CVXCode</Name>
 <Value>214       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>Ebola</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>214</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF</Value>
 <Name>CVXCode</Name>
 <Value>215       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>PneumoPCV</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>152</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF</Value>
 <Name>CVXCode</Name>
 <Value>216       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>PneumoPCV</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>152</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose</Value>
 <Name>CVXCode</Name>
 <Value>217       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose</Value>
 <Name>CVXCode</Name>
 <Value>218       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose</Value>
 <Name>CVXCode</Name>
 <Value>219       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTP-Hib</Value>
 <Name>CVXCode</Name>
 <Value>22        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>DTAP</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>107</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTP-Hib</Value>
 <Name>CVXCode</Name>
 <Value>22        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HIB</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>17</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>HepB recombinant, 3-antigen, Al(OH)3</Value>
 <Name>CVXCode</Name>
 <Value>220       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HepB</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>45</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose</Value>
 <Name>CVXCode</Name>
 <Value>221       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Tick-borne encephalitis, unspecified</Value>
 <Name>CVXCode</Name>
 <Value>222       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>Tick-borne encephalitis</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>222</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Tick-borne encephalitis, inactivated, PF, 0.25mL</Value>
 <Name>CVXCode</Name>
 <Value>223       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>Tick-borne encephalitis</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>222</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Tick-borne encephalitis, inactivated, PF, 0.5mL</Value>
 <Name>CVXCode</Name>
 <Value>224       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>Tick-borne encephalitis</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>222</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL</Value>
 <Name>CVXCode</Name>
 <Value>225       </Value>
 <Name>Status</Name>
 <Value>Never Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL</Value>
 <Name>CVXCode</Name>
 <Value>226       </Value>
 <Name>Status</Name>
 <Value>Never Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose</Value>
 <Name>CVXCode</Name>
 <Value>227       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose</Value>
 <Name>CVXCode</Name>
 <Value>228       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose</Value>
 <Name>CVXCode</Name>
 <Value>229       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>plague</Value>
 <Name>CVXCode</Name>
 <Value>23        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>Plague</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>23</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL</Value>
 <Name>CVXCode</Name>
 <Value>230       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>influenza, Southern Hemisphere, high-dose, quadrivalent</Value>
 <Name>CVXCode</Name>
 <Value>231       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Anthrax, pre-exposure prophylaxis, post-exposure prophylaxis</Value>
 <Name>CVXCode</Name>
 <Value>24        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>ANTHRAX</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>319</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>typhoid, oral</Value>
 <Name>CVXCode</Name>
 <Value>25        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>TYPHOID</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>91</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>cholera, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>26        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>cholera</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>26</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DT (pediatric)</Value>
 <Name>CVXCode</Name>
 <Value>28        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>DTAP</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>107</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose</Value>
 <Name>CVXCode</Name>
 <Value>300       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose</Value>
 <Name>CVXCode</Name>
 <Value>301       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose</Value>
 <Name>CVXCode</Name>
 <Value>302       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF</Value>
 <Name>CVXCode</Name>
 <Value>303       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>RSV</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>304</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Respiratory syncytial virus (RSV), unspecified</Value>
 <Name>CVXCode</Name>
 <Value>304       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>RSV</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>304</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF</Value>
 <Name>CVXCode</Name>
 <Value>305       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>RSV</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>304</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months</Value>
 <Name>CVXCode</Name>
 <Value>306       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>RSV</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>304</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months</Value>
 <Name>CVXCode</Name>
 <Value>307       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>RSV</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>304</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL</Value>
 <Name>CVXCode</Name>
 <Value>308       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL</Value>
 <Name>CVXCode</Name>
 <Value>309       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hep A, pediatric, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>31        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HepA</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>85</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL</Value>
 <Name>CVXCode</Name>
 <Value>310       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL</Value>
 <Name>CVXCode</Name>
 <Value>311       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL</Value>
 <Name>CVXCode</Name>
 <Value>312       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL</Value>
 <Name>CVXCode</Name>
 <Value>313       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Respiratory syncytial virus (RSV) vaccine, unspecified</Value>
 <Name>CVXCode</Name>
 <Value>314       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>RSV</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>304</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Respiratory syncytial virus (RSV) MAB, unspecified</Value>
 <Name>CVXCode</Name>
 <Value>315       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>RSV</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>304</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF</Value>
 <Name>CVXCode</Name>
 <Value>316       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>MENING</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>108</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF</Value>
 <Name>CVXCode</Name>
 <Value>316       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>MeningB</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>164</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Chikungunya live attenuated vaccine, 0.5 mL, PF</Value>
 <Name>CVXCode</Name>
 <Value>317       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>Chikungunya</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>317</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Anthrax, post-exposure prophylaxis</Value>
 <Name>CVXCode</Name>
 <Value>318       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>ANTHRAX</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>319</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Anthrax vaccine, unspecified</Value>
 <Name>CVXCode</Name>
 <Value>319       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>ANTHRAX</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>319</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>meningococcal MPSV4</Value>
 <Name>CVXCode</Name>
 <Value>32        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>MENING</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>108</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Influenza, MDCK, trivalent, preservative</Value>
 <Name>CVXCode</Name>
 <Value>320       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Influenza-avian, H5N8, monovalent, PF</Value>
 <Name>CVXCode</Name>
 <Value>321       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU-Avian-H5</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>323</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Influenza-avian, H5N8, monovalent, preservative</Value>
 <Name>CVXCode</Name>
 <Value>322       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU-Avian-H5</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>323</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Influenza-avian, H5, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>323       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU-Avian-H5</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>323</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Poliovirus, inactivated, fractional-dose (fIPV)</Value>
 <Name>CVXCode</Name>
 <Value>324       </Value>
 <Name>Status</Name>
 <Value>Non-US</Value>
 <Name>Vaccine Group Name</Name>
 <Value>POLIO</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>89</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Vaccinia (smallpox, monkeypox), unspecified</Value>
 <Name>CVXCode</Name>
 <Value>325       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>Orthopoxvirus</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>325</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>RSV, mRNA, injectable, PF</Value>
 <Name>CVXCode</Name>
 <Value>326       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>RSV</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>304</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Pneumococcal conjugate PCV21, polysaccharide CRM197 conjugate, PF</Value>
 <Name>CVXCode</Name>
 <Value>327       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>PneumoPCV</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>152</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Meningococcal oligosaccharide (MenACWY), (MenB), PF</Value>
 <Name>CVXCode</Name>
 <Value>328       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>MeningB</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>164</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Meningococcal oligosaccharide (MenACWY), (MenB), PF</Value>
 <Name>CVXCode</Name>
 <Value>328       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>MENING</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>108</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Chikungunya, VLP, recombinant, 0.8 mL, PF</Value>
 <Name>CVXCode</Name>
 <Value>329       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>Chikungunya</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>317</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>pneumococcal polysaccharide PPV23</Value>
 <Name>CVXCode</Name>
 <Value>33        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>PneumoPPV</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>33</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Dengue fever, unspecified</Value>
 <Name>CVXCode</Name>
 <Value>330       </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>DENGUE</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>330</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Influenza, Southern Hemisphere, trivalent, PF</Value>
 <Name>CVXCode</Name>
 <Value>331       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>RSV, mAb, clesrovimab-cfor, 0.7 mL, neonate and infant, PF</Value>
 <Name>CVXCode</Name>
 <Value>332       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>RSV</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>304</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Influenza, live, trivalent, intranasal, self/caregiver admin, PF</Value>
 <Name>CVXCode</Name>
 <Value>333       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL</Value>
 <Name>CVXCode</Name>
 <Value>334       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Influenza, Southern Hemisphere, high-dose, trivalent, PF</Value>
 <Name>CVXCode</Name>
 <Value>337       </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>tetanus toxoid, adsorbed</Value>
 <Name>CVXCode</Name>
 <Value>35        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>Td</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>139</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>yellow fever live</Value>
 <Name>CVXCode</Name>
 <Value>37        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>YELLOWFEVER</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>184</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>rubella/mumps</Value>
 <Name>CVXCode</Name>
 <Value>38        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>MMR</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>03</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Japanese encephalitis SC</Value>
 <Name>CVXCode</Name>
 <Value>39        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>Japanese encephalitis</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>129</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>rabies, intradermal injection</Value>
 <Name>CVXCode</Name>
 <Value>40        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>RABIES</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>90</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>typhoid, parenteral</Value>
 <Name>CVXCode</Name>
 <Value>41        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>TYPHOID</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>91</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hep B, adolescent/high risk infant</Value>
 <Name>CVXCode</Name>
 <Value>42        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HepB</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>45</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hep B, adult</Value>
 <Name>CVXCode</Name>
 <Value>43        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HepB</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>45</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hep B, high-dosage, dialysis or IC</Value>
 <Name>CVXCode</Name>
 <Value>44        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HepB</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>45</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hep B, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>45        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HepB</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>45</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hib (PRP-D)</Value>
 <Name>CVXCode</Name>
 <Value>46        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HIB</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>17</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hib (HbOC)</Value>
 <Name>CVXCode</Name>
 <Value>47        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HIB</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>17</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hib (PRP-T)</Value>
 <Name>CVXCode</Name>
 <Value>48        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HIB</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>17</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hib (PRP-OMP)</Value>
 <Name>CVXCode</Name>
 <Value>49        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HIB</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>17</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP-Hib</Value>
 <Name>CVXCode</Name>
 <Value>50        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HIB</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>17</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>DTaP-Hib</Value>
 <Name>CVXCode</Name>
 <Value>50        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>DTAP</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>107</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19 Non-US Vaccine, UNSPECIFIED</Value>
 <Name>CVXCode</Name>
 <Value>500       </Value>
 <Name>Status</Name>
 <Value>Non-US</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19 IV Non-US Vaccine (QAZCOVID-IN)</Value>
 <Name>CVXCode</Name>
 <Value>501       </Value>
 <Name>Status</Name>
 <Value>Non-US</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19 IV Non-US Vaccine (COVAXIN)</Value>
 <Name>CVXCode</Name>
 <Value>502       </Value>
 <Name>Status</Name>
 <Value>Non-US</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19 LAV Non-US Vaccine (COVIVAC)</Value>
 <Name>CVXCode</Name>
 <Value>503       </Value>
 <Name>Status</Name>
 <Value>Non-US</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19 VVnr Non-US Vaccine (Sputnik Light)</Value>
 <Name>CVXCode</Name>
 <Value>504       </Value>
 <Name>Status</Name>
 <Value>Non-US</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19 VVnr Non-US Vaccine (Sputnik V)</Value>
 <Name>CVXCode</Name>
 <Value>505       </Value>
 <Name>Status</Name>
 <Value>Non-US</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology</Value>
 <Name>CVXCode</Name>
 <Value>506       </Value>
 <Name>Status</Name>
 <Value>Non-US</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences)</Value>
 <Name>CVXCode</Name>
 <Value>507       </Value>
 <Name>Status</Name>
 <Value>Non-US</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention)</Value>
 <Name>CVXCode</Name>
 <Value>508       </Value>
 <Name>Status</Name>
 <Value>Non-US</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19 PS Non-US Vaccine (EpiVacCorona)</Value>
 <Name>CVXCode</Name>
 <Value>509       </Value>
 <Name>Status</Name>
 <Value>Non-US</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hib-Hep B</Value>
 <Name>CVXCode</Name>
 <Value>51        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HIB</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>17</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hib-Hep B</Value>
 <Name>CVXCode</Name>
 <Value>51        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HepB</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>45</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19 IV Non-US Vaccine (BIBP, Sinopharm)</Value>
 <Name>CVXCode</Name>
 <Value>510       </Value>
 <Name>Status</Name>
 <Value>Non-US</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac)</Value>
 <Name>CVXCode</Name>
 <Value>511       </Value>
 <Name>Status</Name>
 <Value>Non-US</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz)</Value>
 <Name>CVXCode</Name>
 <Value>512       </Value>
 <Name>Status</Name>
 <Value>Non-US</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax)</Value>
 <Name>CVXCode</Name>
 <Value>513       </Value>
 <Name>Status</Name>
 <Value>Non-US</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D)</Value>
 <Name>CVXCode</Name>
 <Value>514       </Value>
 <Name>Status</Name>
 <Value>Non-US</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901)</Value>
 <Name>CVXCode</Name>
 <Value>515       </Value>
 <Name>Status</Name>
 <Value>Non-US</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)</Value>
 <Name>CVXCode</Name>
 <Value>516       </Value>
 <Name>Status</Name>
 <Value>Non-US</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax)</Value>
 <Name>CVXCode</Name>
 <Value>517       </Value>
 <Name>Status</Name>
 <Value>Non-US</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)</Value>
 <Name>CVXCode</Name>
 <Value>518       </Value>
 <Name>Status</Name>
 <Value>Non-US</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna</Value>
 <Name>CVXCode</Name>
 <Value>519       </Value>
 <Name>Status</Name>
 <Value>Non-US</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hep A, adult</Value>
 <Name>CVXCode</Name>
 <Value>52        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HepA</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>85</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech</Value>
 <Name>CVXCode</Name>
 <Value>520       </Value>
 <Name>Status</Name>
 <Value>Non-US</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK</Value>
 <Name>CVXCode</Name>
 <Value>521       </Value>
 <Name>Status</Name>
 <Value>Non-US</Value>
 <Name>Vaccine Group Name</Name>
 <Value>COVID-19</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>213</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>typhoid, parenteral, AKD (U.S. military)</Value>
 <Name>CVXCode</Name>
 <Value>53        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>TYPHOID</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>91</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>adenovirus, type 4</Value>
 <Name>CVXCode</Name>
 <Value>54        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>ADENO</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>82</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>adenovirus, type 7</Value>
 <Name>CVXCode</Name>
 <Value>55        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>ADENO</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>82</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>dengue fever tetravalent</Value>
 <Name>CVXCode</Name>
 <Value>56        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>DENGUE</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>330</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>HPV, quadrivalent</Value>
 <Name>CVXCode</Name>
 <Value>62        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HPV</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>137</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Lyme disease</Value>
 <Name>CVXCode</Name>
 <Value>66        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>Lyme disease</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>66</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>rotavirus, tetravalent</Value>
 <Name>CVXCode</Name>
 <Value>74        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>ROTAVIRUS</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>122</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Vaccinia (smallpox, monkeypox), live</Value>
 <Name>CVXCode</Name>
 <Value>75        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>Orthopoxvirus</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>325</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Tick-borne encephalitis vaccine (non-US)</Value>
 <Name>CVXCode</Name>
 <Value>77        </Value>
 <Name>Status</Name>
 <Value>Non-US</Value>
 <Name>Vaccine Group Name</Name>
 <Value>Tick-borne encephalitis</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>222</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>VEE, live</Value>
 <Name>CVXCode</Name>
 <Value>80        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>VEE</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>92</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>VEE, inactivated</Value>
 <Name>CVXCode</Name>
 <Value>81        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>VEE</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>92</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>adenovirus, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>82        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>ADENO</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>82</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hep A, ped/adol, 2 dose</Value>
 <Name>CVXCode</Name>
 <Value>83        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HepA</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>85</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hep A, ped/adol, 3 dose</Value>
 <Name>CVXCode</Name>
 <Value>84        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HepA</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>85</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>Hep A, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>85        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>HepA</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>85</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>influenza, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>88        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>FLU</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>88</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>polio, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>89        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>POLIO</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>89</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>rabies, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>90        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>RABIES</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>90</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>typhoid, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>91        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>TYPHOID</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>91</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>VEE, unspecified formulation</Value>
 <Name>CVXCode</Name>
 <Value>92        </Value>
 <Name>Status</Name>
 <Value>Inactive</Value>
 <Name>Vaccine Group Name</Name>
 <Value>VEE</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>92</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>MMRV</Value>
 <Name>CVXCode</Name>
 <Value>94        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>MMR</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>03</Value>
 </CVXVGInfo>
 <CVXVGInfo>
 <Name>ShortDescription</Name>
 <Value>MMRV</Value>
 <Name>CVXCode</Name>
 <Value>94        </Value>
 <Name>Status</Name>
 <Value>Active</Value>
 <Name>Vaccine Group Name</Name>
 <Value>VARICELLA</Value>
 <Name>CVX for Vaccine Group</Name>
 <Value>21</Value>
 </CVXVGInfo>
</VGCodes>
